 Yesterday, the VP, ClinicalTranslational Sc of AxoGen AXGNResearch Report,Erick Wayne Devinney, bought shares of AXGN for 683.This recent transaction increases Erick Wayne Devinneys holding in the company by 5.21 to a total of 463.6K. 